Effect of Phenobarbital on Hyperbilirubinemia and Glucuronide Formation in Newborns

American Journal of Diseases of Children

Volumn 120, Issue 1, 1970, Pages 26-31

  Stern, Leo ^a   Khanna, Narinder N ^b   Levy, Gerhard ^c   Yaffe, Sumner J ^c  

^a RESEARCH INSTITUTE OF THE MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^b Catherine Booth Hospital Centre   (Canada)

^c UNIVERSITY AT BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; GLUCURONIC ACID; PHENOBARBITAL; SALICYLAMIDE DERIVATIVE;

ARTICLE; FEMALE; HUMAN; HYPERBILIRUBINEMIA; MALE; METABOLISM; NEWBORN; NEWBORN DISEASE; URINE;

BILIRUBIN; FEMALE; GLUCURONATES; HUMAN; HYPERBILIRUBINEMIA; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; MALE; PHENOBARBITAL; SALICYLAMIDES;

EID: 0014817356     PISSN: 00968994     EISSN: 23742976     Source Type: Journal    
DOI: 10.1001/archpedi.1970.02100060060007     Document Type: Article

References (16)

1. Catz C, Yaffe SJ: Pharmacological modification of bilirubin conjugation in newborn. Amer J Dis Child 104:516-517, 1962.
2. Catz C, Yaffe SJ: Pharmacological modification of bilirubin conjugation in newborn: II. Clearance studies. Read before the Proceedings of the Western Society for Pediatric Research, Seattle, Nov 11-12, 1963.
3. Yaffe SJ, Levy G, Matsuzawa T, et al: Enhancement of glucuronide conjugating capacity in a hyperbilirubinemic infant due to apparent enzyme induction by phenobarbital. New Eng J Med 275:1461-1466, 1966.
4. Crigler F Jr, Gold NI: Sodium phenobarbital induced decrease in serum bilirubin in an infant with congenital non-haemolytic jaundice and kernicterus. J Clin Invest 45:998-999, 1966.
5. Trolle D: Decrease of total serum bilirubin concentration in newborn infants after phenobarbital treatment. Lancet 2:705-708, 1968.
6. Cunningham MD, Mace JW, Peters ER: Clinical experience with phenobarbitone in icterus neonatorum. Lancet 1:550-551, 1969.
7. Ramboer C, Thompson RPH, Williams R: Controlled trials of phenobarbitone therapy in neonatal jaundice. Lancet 1:966-968, 1969.
8. Malloy HT, Evelyn KA: Determination of bilirubin with photoelectric colorimeter. J Biol Chem 119:481-490, 1937.
9. Levy G, Matsuzawa T: Pharmacokinetics of salicylamide elimination in man. J Pharmacol Exp Therap 156:285-293, 1967.
10. Levy G, Procknal JA: Drug biotransformation interactions in man: I. J Pharm Sci 57:1330-1335, 1968.
11. Hepner R, Lubchenko LO: A method for continuous urine and stool collection in young infants. Pediatrics 26:828-831, 1960.
12. Catz C, Yaffe SJ: Barbiturate enhancement of bilirubin conjugation and excretion in young and adult animals. Ped Res 2:361-370, 1968.
13. Roberts RJ, Plaa GL: Effect of phenobarbital on the excretion of an exogenous bilirubin load. Biochem Pharmacol 16:827-835, 1967.
14. Silverman WA, Anderson DH, Blanc WA, et al: A difference in mortality rate and incidence of kernicterus among premature infants, allotted to two prophylactic antibacterial regiments. Pediatrics 18:614-625, 1956.
15. Johnson L, Sarmiento F, Blanc WA, et al: Kernicterus in rats, with an inherited deficiency of glucuronyl transferase. Amer J Dis Child 97:591-608, 1959.
16. Khanna N, Harpur E, Stern L: In-vitro effect of sodium phenobarbital and diethylnicotinamide (coramine) on the protein binding of bilirubin. Clin Biochem 2:349-356, 1969.